SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.170-1.4%Dec 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig Slotoroff who wrote ()2/11/1997 10:27:00 PM
From: Preston Lurie   of 1605
 
American College of Physicians Selects EECP Researcher As Winner In 1997 Competition

STONY BROOK, N.Y.--(BUSINESS WIRE)--February 11,
1997--Krishnamurthy Suresh, M.D. has been selected as a winner in
the 1997 Associates Competition for Research of the American College
of Physicians and will present "Doppler Study of the Hemodynamic
Effects of Enhanced External Counterpulsation" at the American
College of Physicians Annual Scientific Meeting on March 22-25 in
Philadelphia.
Enhanced External Counterpulsation increases blood supply to
vital organs noninvasively, providing similar, and possibly
superior, effects to intra-aortic balloon pumping (IABP), according
to research carried out with EECP(R) equipment, supplied by
Vasomedical, Inc. of Westbury, N.Y.
In a study of 16 subjects at rest and while receiving Enhanced
External Counterpulsation, clinical benefits, including a 63 percent
increase in cardiac output and a 135 percent increase in retrograde
diastolic flow, were demonstrated. These hemodynamic effects
provide a physiologic basis for the observed long-term benefits of
Enhanced External Counterpulsation.
"Enhanced External Counterpulsation may be hemodynamically
superior to intra-aortic balloon pumping," according to Dr. Suresh.
"It increases blood pressure in the aorta and blood flow in the
coronary arteries while the heart is relaxing. These effects help
perfuse the heart muscle and may enhance the development of
collateral circulation."
The study demonstrated that cardiac support with Enhanced
External Counterpulsation is at least comparable to that of IABP.
However, unlike IABP, Enhanced External Counterpulsation increases
venous return. Moreover, it increases cardiac output to a greater
degree than IABP, so it may be more effective as well.
"The noninvasive application of Enhanced External
Counterpulsation offers additional advantages over IABP. While IABP
may be used only for a limited time and can cause a number of
complications related to blood vessel damage, clotting and bleeding,
Enhanced External Counterpulsation can be used repeatedly, and so
far there have been no complications because of bleeding, clotting
or damage to the blood vessels," said Dr. Suresh.
Research with Enhanced External Counterpulsation at the Stony
Brook University Hospital and Medical Center began in 1989. Since
then, nearly 100 patients have been studied at Stony Brook, with
numerous abstracts presented at major medical meetings and several
articles published in peer-reviewed cardiology journals.
People suffering with angina pectoris may receive Enhanced
External Counterpulsation at hospitals and clinics in California,
Colorado, Florida, Georgia, Kentucky, New Jersey, New York, Ohio,
Pennsylvania, and South Carolina. Equipment, treatment guidelines
and staff training are provided by Vasomedical, Inc., Westbury, N.Y.
To interview a leading researcher of Enhanced External
Counterpulsation, or to obtain a press kit or journal reprints,
please call Jeanette Hutter at 215/233-5086 or 800-455-3327,
ext. 791.

cf/ny*

CONTACT: American College of Physicians Jeanette Hutter, 215/233-5086
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext